-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/malone-report.pdf
January 01, 2024 - Final Progress Report: Drug-Drug Interaction Clinical Decision Support Conference Series
Drug-Drug Interaction Clinical Decision Support
Conference Series
Investigators:
Daniel C. Malone, RPh, PhD, Principal Investigator
Mary L. Brown, PhD, Co-Investigator
Lisa E. Hines, PharmD, Co-Investigator
Amy Grizzle, Pha…
-
ce.effectivehealthcare.ahrq.gov/patient-safety/reports/liability/corbett.html
August 01, 2017 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy
Evidence-based Practice Center Systematic Review Protocol
Project Title: Postpartum Care for Women Up to One Year After Pregnancy
Initial Publication Date: February 24, 2022
Amendment Date: April 25, 2022
(Amendments Details-see Section VI…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
October 05, 2012 - Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1273
Published Online: October 5, 2012
Comparative Effectiveness Research Review Disposition of Comments Report
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_disposition-comments.pdf
April 02, 2013 - Disposition of Comments for Interventions for the Prevention of Posttraumatic Stress Disorder (PTSD) in Adults After Exposure to Psychological Trauma
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Interventions for the Prevention of Posttraumatic Stress Disorde…
-
www.ahrq.gov/sites/default/files/2024-01/malone-report.pdf
January 01, 2024 - Final Progress Report: Drug-Drug Interaction Clinical Decision Support Conference Series
Drug-Drug Interaction Clinical Decision Support
Conference Series
Investigators:
Daniel C. Malone, RPh, PhD, Principal Investigator
Mary L. Brown, PhD, Co-Investigator
Lisa E. Hines, PharmD, Co-Investigator
Amy Grizzle, Pha…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_disposition-comments.pdf
April 02, 2013 - Disposition of Comments for Interventions for the Prevention of Posttraumatic Stress Disorder (PTSD) in Adults After Exposure to Psychological Trauma
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Interventions for the Prevention of Posttraumatic Stress Disorde…
-
digital.ahrq.gov/sites/default/files/docs/page/privacy-and-security-solutions-for-interoperable-hie-avas-executive-summary.pdf
June 30, 2007 - Privacy and Security Solutions for Interoperable Health Information Exchange - Assessment of Variation and Analysis of Solutions - Executive Summary
June 30, 2007
Privacy and Security Solutions for
Interoperable Health Information
Exchange
Assessment of Variation and
Analysis of Solutions
Executive…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy
Evidence-based Practice Center Systematic Review Protocol
Project Title: Postpartum Care for Women Up to One Year After Pregnancy
Initial Publication Date: February 24, 2022
Amendment Date: April 25, 2022
(Amendments Details-see Section VI…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
October 05, 2012 - Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1273
Published Online: October 5, 2012
Comparative Effectiveness Research Review Disposition of Comments Report
…
-
effectivehealthcare-admin.ahrq.gov/products/postpartum-care-one-year/protocol
December 01, 2022 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
www.ahrq.gov/hai/cusp/toolkit/content-calls/engagement.html
April 01, 2013 - Physician Engagement (Transcript)
September 13, 2011
Operator: Excuse me, everyone, we now have our speakers in conference. Please be aware that each of your lines is in a listen-only mode. At the conclusion of the presentation, we will open the floor for questions. At that time, instructions will be given i…